Cyclooxygenase-2 in CRC is associated with poorer tumour indices of high tumour grade and stage (tumour invasion), and could influence tumour immunity in the hosts either by modulating lymphocytic response to tumour cells or by recruiting T-regulatory lymphocytes thus promoting tumour progression. The gene discussed is PTGS2; the disease is colorectal carcinoma.